Transcatheter Mitral Valve Implantation (TMVI) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Transcatheter Mitral Valve Implantation (TMVI) Pipeline Market Report Overview
The Transcatheter Heart Valve is an artificial heart valve made up of natural tissue (biological material mainly derived from cow or bovine) surrounded by a flexible mesh frame known as stent (made of steel or cobalt-chromium), all placed in a long narrow tube known as a catheter. The catheter is inserted into a large blood vessel in the groin area (transfemoral) or through a small incision in chest (transapical).
The TMVI pipeline market research report provides comprehensive information about the Transcatheter Mitral Valve Implantation (TMVI) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
TMVI Pipeline Market Segmentation by Territories
Some of the key territories in the TMVI pipeline market are the US, China, Europe, Canada, Israel, Macau, Taiwan, the UK, and Hong Kong. In 2023, the US has the highest number of pipeline products.
TMVI Pipeline Market Analysis, by Territories, 2023 (%)
For more territory insights into the TMVI pipeline market, download a free report sample
TMVI Pipeline Market Segmentation by Regulatory Paths
The key regulatory paths in the TMVI pipeline market are PMA, NMPA, CE, MDL, BOPA, MDCO, and UKCA. In 2023, PMA is the most followed pathway for TMVI pipeline products.
TMVI Pipeline Market Analysis, by Regulatory Paths, 2023 (%)
For more regulatory paths insights into the TMVI pipeline market, download a free report sample
TMVI Pipeline Market- Competitive Landscape
Some of the key companies in the TMVI pipeline market are 4C Medical Technologies Inc, Abbott Vascular Inc, Annulon, Cardiovalve Ltd, Cephea Valve Technologies, Inc., Colibri Heart Valve LLC, Direct Flow Medical Inc (Inactive), Edwards Lifesciences Corp, Emory University, and Foldax Inc.
4C Medical Technologies Inc: 4C Medical is a medical device company developing minimally invasive therapies for structural heart disease, focusing initially on mitral regurgitation (MR) therapy and subsequently on tricuspid regurgitation therapy. The company’s implant is the first MR therapy with supra-annular positioning and atrial-only fixation. It preserves the native mitral valve and left ventricle, eliminating known issues associated with transcatheter mitral valve replacement technologies which rely on placement and fixation in the native mitral annulus and left ventricle.
Abbott Vascular Inc: Headquartered in Santa Clara, California, the US, Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. Its coronary intervention products include bleedback control valve, coronary dilatation catheters, coronary drug eluting stents, coronary guide wires, and others. Abbott Vascular’s peripheral intervention products comprise peripheral guide wires, dilatation catheters, guiding catheters, and stent grafts. The company provides minimally invasive treatment for mitral regurgitation and other structural defects of the heart. It also offers education and training services for healthcare professionals.
TMVI Pipeline Market Report Overview
Key Territories | The US, China, Europe, Canada, Israel, Macau, Taiwan, the UK, and Hong Kong |
Key Regulatory Paths | PMA, NMPA, CE, MDL, BOPA, MDCO, and UKCA |
Leading Companies | 4C Medical Technologies Inc, Abbott Vascular Inc, Annulon, Cardiovalve Ltd, Cephea Valve Technologies, Inc., Colibri Heart Valve LLC, Direct Flow Medical Inc (Inactive), Edwards Lifesciences Corp, Emory University, and Foldax Inc |
Segments Covered in the Report
TMVI Pipeline Market Territory Outlook
- The US
- China
- Europe
- Canada
- Israel
- Macau
- Taiwan
- The UK
- Hong Kong
TMVI Pipeline Market Regulatory Path Outlook
- PMA
- NMPA
- CE
- MDL
- BOPA
- MDCO
- UKCA
Scope
- Extensive coverage of the Transcatheter Mitral Valve Implantation (TMVI) under development
- Reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- Reviews the major players involved in the development of Transcatheter Mitral Valve Implantation (TMVI) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- Provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Transcatheter Mitral Valve Implantation (TMVI) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Abbott Vascular Inc
Annulon
Cardiovalve Ltd
Cephea Valve Technologies, Inc.
Colibri Heart Valve LLC
Direct Flow Medical Inc (Inactive)
Edwards Lifesciences Corp
Emory University
Foldax Inc
Jenscare Scientific Co Ltd
Jiangsu Zhenyi Medical Technology Co Ltd
Lepu Medical Technology (Beijing) Co Ltd
LivaNova PLC
Medtronic Plc
Micro Interventional Devices, Inc.
MicroPort CardioFlow Medtech Corp
MicroPort Scientific Corp
MitrAssist Ltd.
MValve Technologies Ltd.
Neovasc Inc
NewMed Medical Co Ltd
P+F Products + Features GmbH
Polares Medical SA
Shanghai Shenqi Medical Technology Co Ltd
Sino Medical Sciences Technology Inc
Symetis SA
Tioga Medical Inc
Trinity College Dublin
University College London
Valcare Medical
Venus Medtech Hangzhou Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory has the highest number of pipeline products in the TMVI pipeline market in 2023?
In 2023, the US has the highest number of pipeline products in the TMVI pipeline market.
-
Which is the most followed regulatory pathway in the TMVI pipeline market in 2023?
In 2023, PMA is the most followed regulatory pathway in the TMVI pipeline market.
-
Who are the major players operating in the TMVI pipeline market?
Some of the major players operating in the TMVI pipeline market are 4C Medical Technologies Inc, Abbott Vascular Inc, Annulon, Cardiovalve Ltd, Cephea Valve Technologies, Inc., Colibri Heart Valve LLC, Direct Flow Medical Inc (Inactive), Edwards Lifesciences Corp, Emory University, and Foldax Inc.
-
What is a Transcatheter Heart Valve?
A Transcatheter Heart Valve is an artificial heart valve made up of natural tissue (biological material mainly derived from cow or bovine) surrounded by a flexible mesh frame known as stent (made of steel or cobalt-chromium), all placed in a long narrow tube known as a catheter.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.